Biora Therapeutics, Inc. Treasury Stock, Common, Value
Biora Therapeutics, Inc. had Treasury Stock, Common, Value of $19.08 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:TreasuryStockCommonValue · last filed 2024-11-14
- 2024-09-30: Treasury Stock, Common, Value $19.08M.
- 2024-06-30: Treasury Stock, Common, Value $19.08M.
- 2024-03-31: Treasury Stock, Common, Value $19.08M.
- 2023-12-31: Treasury Stock, Common, Value $19.08M; Treasury Stock, Common, Value as first filed $19.08M.
| Period end | Treasury Stock, Common, Value | Treasury Stock, Common, Value as first filed |
|---|---|---|
| 2024-09-30 | $19.08M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $19.08M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $19.08M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $19.08M 10-Q · filed 2024-11-14 | $19.08M 10-K · filed 2024-04-01 |
| 2023-09-30 | $19.08M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $19.08M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $19.08M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $19.08M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $19.08M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $19.08M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $19.08M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $19.08M 10-K · filed 2023-03-30 | $19.08M 10-K · filed 2022-03-28 |
| 2021-09-30 | $18.78M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $18.78M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $18.77M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $18.77M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $18.77M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $18.77M 10-Q · filed 2020-08-14 | |
| 2019-12-31 | $18.77M 10-K · filed 2021-03-18 |